1004551-07-8Relevant articles and documents
Synthesis, conformational analysis, and biological evaluation of 1-hexylindolactam-V10 as a selective activator for novel protein kinase C isozymes
Yanagita, Ryo C.,Nakagawa, Yu,Yamanaka, Nobuhiro,Kashiwagi, Kaori,Saito, Naoaki,Irie, Kazuhiro
, p. 46 - 56 (2008/09/18)
Conventional and novel protein kinase C (PKC) isozymes are the main targets of tumor promoters. We developed 1-hexylindolactam-V10 (5) as a selective activator for novel PKC isozymes that play important roles in various cellular processes related to tumor